Biocon  kicked off a series of patient outreach programs to mark a decade of excellence in affordable insulin therapy, through which it has been touching the lives of lakhs of diabetic patient.

Bicon was an early pioneer in the development of generic recombinant human insulin (rh-Insulin) and introduced it to patients in India in 2004. As a part of the initiative, special programs like health camps for senior citizens are being organised in several cities across India.

The company's engagement with the senior citizens who underwent screening at the health camp will extend to subsidized / free lifetime medication (oral cardio, anti- diabetics & insulin) and distribution of free optical devices.

Ravindra Limaye, president, marketing Biocon said, "The instances of chronic morbidities like diabetics and hypertension among the geriatric population are constantly increasing. Also, as age advances, this is the population which is neglected worldwide. Proper diagnosis and timely treatment are key in reducing the burden of illness and associated costs."

Shares of the company gained Rs 4.25, or 0.93%, to trade at Rs 463.05. The total volume of shares traded was 20,706 at the BSE (11.03 a.m., Monday).